Credit Analysis: GILSON SCIENTIFIC LIMITED

1. Credit Opinion: CONDITIONAL

Reasoning: Gilson Scientific Limited presents an acceptable but not straightforward credit profile. The company operates as a UK subsidiary within an international group structure (ultimately owned by Gilson Scientific Inc, with Gilson International B.V. as the European parent), and its financial statements are heavily influenced by intercompany transactions and balances. While the balance sheet shows a positive and improving net asset position (£1,302k in 2025, up from £804k in 2021), the going concern basis is explicitly dependent on continued group financial support. The significant decline in cash reserves (from £778k to £364k) and the substantial intercompany debtor balance (£3,798k - a 65% year-on-year increase) raise standalone liquidity concerns. Credit can be extended, but with appropriate safeguards including a parent company guarantee.

2. Financial Strength

Balance Sheet Summary (£000s):

Key Ratios:

Analysis:

• Positive trajectory: Net assets have grown consistently from £804k (2021) to £1,302k (2025), demonstrating accumulation of retained profits. Share capital is fully paid at £400k.
• Balance sheet composition concern: Current assets are dominated by debtors (£3,798k of £4,677k total), which the accounts confirm are heavily intercompany in nature. This inflates the current ratio and overstates standalone liquidity.
• Leverage increasing: Total liabilities to net assets has risen from 2.05x to 2.74x, driven primarily by increased intercompany creditor balances. While this is common in group structures, it means the company's obligations to related parties have grown substantially.
• Deferred tax provision: £53k has remained static, suggesting no significant changes in timing differences.

3. Cash Flow Assessment

Liquidity Position:

Assessment:

• Cash deterioration is significant: Cash has fallen by 53% year-on-year. While the company remains cash-positive, the rate of decline warrants attention. The cash decline coincides with a substantial increase in debtors, suggesting cash is tied up in intercompany receivables.
• Working capital is intercompany-dependent: The £1,496k increase in debtors and £1,001k increase in creditors are almost certainly intercompany balances. Net intercompany working capital (debtors minus creditors) shows approximately £495k net receivable from group entities. This means the company is effectively providing working capital funding to the group.
• Standalone cash generation is weak: The P&L reserve increased by only £47k (from £855k to £902k), suggesting modest profitability. Cash generation does not appear sufficient to fund working capital growth without group support.
• Going concern relies on parent letter of support: The accounts explicitly state the company is dependent on continued group support and reference a formal letter from Gilson International B.V. This is a material qualification - without group backing, the standalone entity would face liquidity challenges.

4. Monitoring Points

Specific Monitoring Recommendations:

1. Obtain parent company guarantee before extending any significant credit facility. The going concern is explicitly dependent on group support - this must be contractually backed.
2. Request group financial information to assess the creditworthiness of Gilson International B.V. and Gilson Scientific Inc. Standalone assessment is insufficient.
3. Monitor intercompany net position: If the company shifts from being net intercompany receivable to net payable, liquidity risk increases materially.
4. Resolve the overdue confirmation statement - this is a compliance failure that, while minor, suggests administrative lapses.
5. Track cash position quarterly - the declining trend from £878k to £364k over four years is concerning even within a group structure.